CFO4Life’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.14M Buy
+12,112
New +$2.09M 0.45% 44
2016
Q4
$421K Sell
3,657
-196
-5% -$22.6K 0.35% 51
2016
Q3
$455K Sell
3,853
-1,674
-30% -$203K 0.39% 43
2016
Q2
$670K Buy
5,527
+1,955
+55% +$222K 0.57% 29
2016
Q1
$386K Buy
3,572
+495
+16% +$51.2K 0.35% 52
2015
Q4
$316K Buy
3,077
+7
+0.2% +$704 0.3% 50
2015
Q3
$287K Sell
3,070
-87
-3% -$8.42K 0.31% 50
2015
Q2
$308K Buy
3,157
+100
+3% +$10K 0.26% 59
2015
Q1
$307K Buy
3,057
+6
+0.2% +$610 0.26% 59
2014
Q4
$319K Buy
+3,051
New +$322K 0.26% 54

Other funds holding JNJ

CFO4Life's JNJ Position: Q4 2022 in Review

CFO4Life opened a new position in Johnson & Johnson (JNJ) in Q4 2022: 12,112 shares worth $2.14M. The stake represents 0.45% of the portfolio and ranks #44 among its holdings. This is a return to the name: CFO4Life previously reported a position in JNJ as recently as Q4 2016.

CFO4Life first reported a position in JNJ in Q4 2014 and has held it in 10 quarters since. 3,791 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • CFO4Life held 12,112 shares of Johnson & Johnson worth $2.14M as of Q4 2022.
  • Johnson & Johnson was a new CFO4Life position in Q4 2022.
  • Johnson & Johnson made up 0.45% of CFO4Life's portfolio in Q4 2022, its #44 holding.
  • CFO4Life first reported a position in Johnson & Johnson in Q4 2014 and has held it in 10 quarters since.
  • 3,791 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on CFO4Life's 13F filing for Q4 2022, filed 11 Jan 2023.